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APPENDIX
Versions of draft legislation included in the Second and Third
Reports of the Attorney General's Research Working Group are
reprinted in this Appendix for convenience. Citations to the draft
legislation in the articles published in this issue refer to the actual
page numbers of each report. The aforementioned reports are on file
with the Office of the Maryland Attorney General as well as the Journal







RESEARCH - PROTECTION OF DECISIONALLY
INCAPACITATED INDIVIDUALS
SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY
OF MARYLAND, That the Laws of Maryland read as follows:
ARTICLE - HEALTH GENERAL
Title 20. Miscellaneous Health Provisions.
Subtitle 5. Research Involving Decisionally Incapacitated Individuals
20-501. LEGISIATIW FINDINGS.
The General Assembly finds that:
(a) All research involving human subjects in this State, includ-
ing research involving decisionally incapacitated individuals, should
be conducted with the utmost respect for the well-being and dignity of
each research subject.
(b) Except under the carefully limited circumstances set forth
in this subtitle, all research involving human subjects in this State
should be conducted only after each subject provides informed con-
sent to participation in the research.
(c) Research involving decisionally incapacitated individuals
may be essential under some circumstances if science is to understand
and ultimately combat diseases of the brain, including Alzheimer's
Disease, severe psychiatric disorders, severe trauma, stroke, and other
causes of decisional incapacity.
(d) Researchers should seek to enroll decisionally incapaci-
tated individuals as research subjects only if the research is likely to
yield generalizable knowledge important to the understanding or
amelioration of the subjects' disorder or condition, and the knowl-
edge cannot be obtained without their participation.
20-502. DEFINITIONS.
(a) In this subtitle, the following terms have the meanings
indicated.
(b) "Advance directive authorizing research participation" means
an advance directive made in accordance with §5-602 of this article
that states a desire of an individual to participate in research.
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(c) "Assent" means an individual's affirmative agreement to
participate in research.
(d) "Common Rule" means the federal regulations governing
the protection of human subjects in research codified at 45 C.F.R.
Part 46, Subpart A.
(e) (1) "Decisionally incapacitated individual" means an individual
who is at least 18 years of age and who cannot give a valid informed
consent for research participation because the individual cannot suffi-
ciently understand the nature, extent, or probable consequences of
the proposed research participation, cannot make a sufficient evalua-
tion of burdens, risks, and benefits of the proposed research participa-
tion, or cannot communicate a decision.
(2) An individual who is able to communicate by means other
than speech may not be considered incapable of giving informed con-
sent solely by reason of the inability to speak.
(f) "Health care agent"means an adult appointed by an individ-
ual under an advance directive and authorized under the Health Care
Decisions Act to make health care decisions for the individual.
(g) "Health Care Decisions Act" means Title 5, Subtitle 6 of this
article.
(h) "Informed consent' means the voluntary agreement by an
individual to participate in research following disclosure to the indi-
vidual of all information required to be disclosed by the Common
Rule.
(i) "Investigato' means a person who conducts research by
means of:
(1) physical procedures by which data are gathered from a
living individual;
(2) manipulation of an individual or the individual's
environment;
(3) communication or interpersonal contact between an in-
vestigator and individual; or
(4) gathering individually identifiable private information, in-
cluding information about behavior that occurs in a context in which
an individual can reasonably expect that no observation or recording
is taking place and information which has been provided for specific
purposes by an individual and which the individual can reasonably
expect will not be made public.
(j) "IRB" means an institutional review board whose member-
ship and processes comply with the requirements of the Common
Rule.
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(k) "Legally authorized representative" means an individual au-
thorized under this subtitle to give consent to a decisionally incapaci-
tated individual's participation in research.
(1) "Medical best interest"means that the potential medical ben-
efits to the individual resulting from participation in research are de-
termined by the legally authorized representative to be reasonable in
relation to the burdens to the individual resulting from that participa-
tion in research, taking into account:
(1) the effect of the participation in research on the physical,
emotional, and cognitive functions of the individual;
(2) the degree of physical pain or discomfort, psychological
distress, or loss of dignity caused to the individual by the participation
in research;
(3) the prognosis of the individual;
(4) the risks, side effects, and benefits of the participation in
research, compared to the risks, side effects, and benefits of standard
treatment, if any;
(5) the religious beliefs and basis values of the individual, to
the extent these may assist the legally authorized representative in de-
termining medical best interest.
(in) "Minimal risk" means that the probability and magnitude
of harm or discomfort anticipated in the research, including psycho-
logical harm and loss of dignity, are not greater in and of themselves
than those ordinarily encountered in daily life or during the perform-
ance of routine physical or psychological examinations or tests.
(n) "Minor increase over minimal risk" means that the
probability and magnitude of harm or discomfort anticipated in the
research, including psychological harm and loss of dignity, are only
slightly greater in and of themselves than those ordinarily encoun-
tered in the daily life of the potential research subjects or during the
performance or routine physical or psychological examinations or
tests.
(o) "Monitor" means an adult who is not a health care agent,
research agent, or surrogate for a decisionally incapacitated individual
and who is designated by an IRB to carry out an action authorized
under this subtitle.
(p) "Reasonable prospect of direct medical benefit" means that, on
the basis of scientific evidence, a realistic possibility exists that an indi-
vidual's medical condition would be improved as a direct result of par-
ticipation in research, including ameliorating symptoms or avoiding
side effects of standard therapy.
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(q) "Research" means a systematic investigation including de-
velopment, testing, and evaluation, designed to develop or contribute
to generalizable knowledge.
(r) "Research agent" means an adult who, under an advance di-
rective authorizing research participation, is expressly authorized to
make decisions regarding an individual's participation in research,
whether or not the research agent is also a health care agent or
surrogate.
(s) "Surrogate" means an adult authorized to make health care
decisions for an individual under §5-605 of this article.
20-503. COMPLIANCE WITH SUBTITLE; EXCEPTIONS.
(a) Except for research identified in subsection (b) of this
section, an investigator may not involve a decisionally incapacitated
individual as a subject in research unless all applicable requirements
of this subtitle are satisfied.
(b). This subtitle does not apply to research that:
(1) is exempt under 45 C.F.R. §46.101(b) from the require-
ments of the Common Rule;
(2) concerns treatment for a life-threatening emergency and
is conducted in accordance with regulations of the United States Food
and Drug Administration or a waiver of informed consent by the
United States Department of Health and Human Services; or
(3) involves a decisionally incapacitated individual as a result
of the consent of a court or guardian of the person, acting in accord-
ance with Title 13, Subtitle 7 of the Courts and Judicial Proceedings
Article.
20-504. DUTIES OF AN IRB.
(a) In considering whether to approve research in which deci-
sionally incapacitated individuals are intended to be the subjects, an
IRB shall comply with all requirements applicable to an IRB under the
Common Rule and this subtitle.
(b)(1) An IRB may not approve research in which decisionally
incapacitated individuals are intended to be the subjects unless the
research relates directly to:
(i) the condition that has resulted in the decisional inca-
pacity of the subjects; or
(ii) a demonstrated or reasonably predicted relationship
between that condition and any other medical condition of those
subjects.
(c) An IRB shall determine and state in its minutes whether
or not research in which decisionally incapacitated individuals are in-
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tended to be the subjects presents, to those subjects, a reasonable
prospect of direct medical benefit.
(d) (1) An IRB shall determine and state in its minutes whether
research in which decisionally incapacitated individuals are intended
to be the subjects presents, to those subjects:
(i) minimal risk;
(ii) a minor increase over minimal risk; or
(iii) more than a minor increase over minimal risk.
(2) In determining the degree of risk to that class .of subjects,
the IRB shall take into account:
(i) the extent to which the research adds to the
probability or magnitude of harm or discomfort that the subjects
would experience if they did not participate in the research;
(ii) whether the research has been identified by the
United States Department of Health and Human Services as a cate-
gory for which expedited review procedures are authorized under the
Common Rule; and
(iii) prior research of a similar kind, relevant laboratory
and animal studies, and any other relevant information presented to
the IRB.
(3) An IRB may not determine that research presents a mini-
mal risk if the research would expose the class of subjects who are
intended to be enrolled in the research to a loss of dignity greater
than that ordinarily encountered by individuals who are not decision-
ally incapacitated in daily life or during the performance of routine
physical or psychological examinations or tests.
(4) An IRB may not certify research as presenting a minimal
risk or a minor increase over minimal risk if the research would ex-
pose the class of subjects who are intended to be enrolled in the re-
search to the reasonable possibility of:
(i) severe or prolonged pain or discomfort; or
(ii) deterioration in a medical condition.
(e) An IRB may not approve research in which decisionally
incapacitated individuals are intended to be the subjects unless the
IRB has reviewed and approved:
(1) informed consent procedures and documents consistent
with the Common Rule, including, as appropriate, an explanation of
randomization, the use of a placebo, or other aspects of the control
element of a research design; and
(2) a procedure for soliciting assent from each decisionally
incapacitated individual who is capable of providing assent.
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(f) An IRB may not approve research in which decisionally
incapacitated individuals are intended to be the subjects if the IRB is
aware that an investigator involved in the research has, within the pre-
ceding five years, been found by an agency of the United States or this
State to have knowingly and willfully involved a decisionally incapaci-
tated individual in research in violation of this subtitle.
(g) An IRB shall establish standards and procedures under
which a health care agent shall document, in accordance with § 20-
509(c) (2), the direct and explicit evidence of a decisionally incapaci-
tated individual's wish to participate in research.
(h) (1) An IRB shall assure that any member of the public may
obtain, upon request, the following documents related to research in-
volving decisionally incapacitated individuals that is approved by the
IRB on or after October 1, 1998:
(i) the relevant portions of the IRB's minutes;
(ii) if not included in the IRB's minutes, a summary or
precis of the research; and
(iii) written consent documents approved by the IRB.
(2) Disclosure of these documents may be made by the IRB,
or, by agreement with the IRB, an investigator, a sponsor of research,
or an institution with which the IRB is affiliated.
(3) The person responsible for disclosure may charge a rea-
sonable fee for copies.
(4) The disclosure required by this subsection is in addition
to any disclosure of information or documents related to research that
is required or authorized by:
(i) federal or State law or policy; or
(ii) the policy of the IRB, a sponsor of research, an insti-
tution with which the IRB is affiliated, or an institution at which re-
search occurs.
20-505. DuTIEs OF AN INVESTIGATOR.
(a) An investigator who conducts research involving decision-
ally incapacitated individuals shall comply with all requirements appli-
cable to an investigator under the Common Rule and this subtitle.
(b) Before involving a decisionally incapacitated individual as
a subject in research, an investigator shall:
(1) obtain approval from an IRB to conduct the research;
(2) determine that the individual may participate in the re-
search because:
(i) the individual is one of a class of decisionally inca-
pacitated individuals whose participation in the research has been ap-
proved by the IRB;
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(ii) the research presents a reasonable prospect of direct
medical benefit to the individual; or
(iii) the research falls within a category of research iden-
tified in an advance directive of the individual authorizing research
participation;
(3) in accordance with procedures and documents approved
by an IRB, provide a legally authorized representative with all of the
information required under the Common Rule for informed consent;
and
(4) obtain permission form a legally authorized representa-
tive of the individual; and
(c) unless the individual is unconscious, prior to the partici-
pation in research of a decisionally incapacitated individual, the inves-
tigator shall tell the individual, in a manner appropriate to the
individual's capacity for understanding, that:
(i) he or she is to participate in research; and
(ii) a legally authorized representative has consented to
the individual's participation.
(d) (1) Except as otherwise authorized by law, an investigator
may not compel a decisionally incapacitated individual to perform an
action related to the research if the individual refuses to take the ac-
tion after being asked to do so.
(2) An investigator may take reasonable, noncoercive steps to
encourage a decisionally incapacitated individual to perform an
action.
(e) An investigator who seeks IRB approval of research involv-
ing decisionally incapacitated individuals shall inform the IRB
whether:
(1) any other IRB has failed to approve the research or sub-
stantially equivalent research proposed by the investigator; and
(2) any investigator involved in the research has, within the
preceding five years, been found by an agency of the United States or
this State to have knowingly and willfully involved a decisionally inca-
pacitated individual in research in violation of this subtitle.
20-506. PRIoRITv TO GUARDIANSHIP.
Nothing in this subtitle authorizes a legally authorized represen-
tative to consent to a decisionally incapacitated individual's participa-
tion in research if a guardian of the person has been appointed for
the individual and has been granted authority to made decisions
about research participation.
20-507. EXPECTED BENEFIT RESEARCH.
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(a) This section applies to research that:
(1) presents a reasonable prospect of direct medical benefit
to the class of decisionally incapacitated individuals who have been
authorized by an IRB to be enrolled in the research; or
(2) pertains to a disorder or condition of a decisionally inca-
pacitated individual and presents a reasonable prospect of direct med-
ical benefit to that individual.
(b) A research agent may consent to a decisionally incapaci-
tated individual's participation in research described in this section if,
after taking into account treatment alternatives outside of the re-
search, the research agent concludes that participation in the re-
search is in the individual's medical best interest.
(c) A health care agent may consent to a decisionally incapac-
itated individual's participation in research described in this section
if:
(1) a research agent is not available; and
(2) after taking into account treatment alternatives outside of
the research, the health care agent concludes that participation in the
research is in the individual's medical best interest.
(d) (1) A surrogate may consent to a decisionally incapacitated
individual's participation in research described in this section if:
(i) neither a research agent nor a health care agent is
available; and
(ii) after taking into account treatment alternatives
outside of the-research, the surrogate concludes that participation in
the research is in the individual's medical best interest.
(2) If surrogates with equal decision making priority under
the Health Care Decisions Act disagree about the individual's partici-
pation in the research, the disagreement shall be resolved in accord-
ance with §5-605(b) of this article.
(e) A monitor designated in accordance with §20-511 may
consent to a decisionally incapacitated individual's participation in re-
search described in this section if:
(1) no health care agent, research agent, or surrogate is
available;
(2) the research is unambiguously included in the individ-
ual's advance directive authorizing research participation; and
(3) after taking into account treatment alternatives outside of
the research, the monitor concludes that participation in the research
is in the individual's medical best interest.
(f) Nothing in this section authorizes a surrogate or a moni-
tor to consent to:
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(1) the admission of a decisionally incapacitated individual to
a mental health facility; or
(2) a behavior modification program involving aversive
stimuli.
20-508. No EXPECTED BENEFIT RESEARCH - MINIMAL RISK.
(a) This section applies to research involving a decisionally
incapacitated individual that, as determined by an IRB:
(1) does not provide a reasonable prospect of direct medical
benefit; and
(2) presents no greater than minimal risk to the class of sub-
jects who are authorized to be enrolled in the research.
(b) A research agent, if available, may consent to a decision-
ally incapacitated individual's participation in research described in
this section if the research agent concludes, on the basis of the ad-
vance directive and other pertinent information, that the individual
would consent to participate in the research were the individual able
to give informed consent.
(c) A health care agent may consent to a decisionally incapac-
itated individual's participation in research described in this section
if:
(1) a research agent is not available; and
(2) the health care agent concludes that the individual would
consent to participate in the research were the individual able to give
informed consent.
(d) (1) A surrogate may consent to a decisionally incapacitated
individual's participation in research described in this section if:
(i) neither a research agent.nor a health care agent is
available; and
(ii) the surrogate concludes that the individual would
consent to participate in the research were the individual able to give
informed consent.
(2) If two or more surrogates with equal decision making pri-
ority under the Health Care Decisions Act are available, the individual
may participate in the research only if all surrogates agree to consent
to the individual's participation.
(e) A monitor may consent to a decisionally incapacitated in-
dividual's participation in research described in.this section if:
(1) no research agent, health care agent, or surrogate is avail-
able; and
(2) the research is unambiguously included in the individ-
ual's advance directive authorizing research participation.
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(f) Nothing in this section authorizes a surrogate or a moni-
tor to consent to:
(1) the admission of a decisionally incapacitated individual to
a mental health facility; or
(2) a behavior modification program involving aversive
stimuli.
20-509. No EXPECTED BENEFIT RESEARCH - MINOR INCREASE OVER MINI-
MAL RISK.
(a) • This section applies to research involving a decisionally
incapacitated individual that, as determined by an IRB:
(1) does not provide a reasonable prospect of direct medical
benefit; and
(2) present no more than a minor increase over minimal risk
to the class of subjects who are authorized to be enrolled in the
research.
(b) A research agent may consent to a decisionally incapaci-
tated individual's participation in research described in this section if
the research agent concludes, based on the advance directive author-
izing research participation and other pertinent information, that the
individual would consent to participate in the research were the indi-
vidual able to give informed consent.
(c) A health care agent may consent to a decisionally incapac-
itated individual's participation in research described in this section
if:
(1) a research agent is not available; and
(2) the health care agent determines, based on direct and ex-
plicit evidence of the individual's wish to participate in this research,
as documented in accordance with standards and procedures deter-
mined by the IRB, that the individual would consent to participate in
the research were the individual able to give informed consent.
(d) The individual's prior participation in similar research,
when the individual was able to give informed consent, may be taken
into account by the research agent or health care agent but may not
be the sole basis on which permission is granted for the individual to
participate in the research.
20-510. No EXPECTED BENEFIT RESEARCH - MORE THAN MINOR IN-
CREASE OVER MINIMAL RISK.
(a) This section applies to research involving a decisionally
incapacitated individual that, as determined by an IRB:
(1) does not provide a reasonable prospect of direct medical
benefit; and
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(2) presents more than a minor increase over minimal risk.
(b) A research agent may consent to a decisionally incapaci-
tated individual's participation in research described in this section if:
(1) a monitor confirms that:
(i) the research is unambiguously included in the indi-
vidual's advance directive authorizing research participation; and
(ii) the research agent understands the goals and risks of
the research; and
(2) the research agent concludes that the individual would
consent to participate in the research were the individual able to give
informed consent.
20-511. DESIGNATION AND DUTIES OF MONITOR.
(a) An IRB may designate one or more monitors for research
conducted in the institution served by the IRB.
(b).(1) A monitor may not participate in any way, including au-
thorship of publications, in the research concerning which the moni-
tor performs duties under this subtitle.
(2) If feasible, an IRB shall designate as a monitor an individ-
ual who is not employed by the same institution that employs any in-
vestigator in the research about which the monitor will carry out a
duty.
(c) Upon request of an IRB, a monitor shall:
(1) consider whether to consent to research participation by a
decisionally incapacitated individual, in accordance with §20-507(e)
or §20-508(e); and
(2) verify, in accordance with §20-510(b)(1), that:
(i) research is unambiguously included in an individual's
advance directive authorizing research participation; and
(ii) a research agent understands the goals and risks of
the research.
20-512. WITHDRAWAL FROM RESEARCH.
A legally authorized representative who consents to a decisionally
incapacitated individual's participation in research shall:
(1) take reasonable steps to learn whether the experience of
the individual in the research is consistent with the expectations of
the legally authorized representative at the time that consent was
granted; and
(2) withdraw consent if continued participation by the indi-
vidual would, considering all relevant circumstances, be detrimental
to the well-being of the individual.
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20-513. IMMUNITY FROM LIABILITY; UNPROFESSIONAL CONDUCT.
(a) If research involving decisionally incapacitated individuals
is authorized under this subtitle, an investigator is not subject to crimi-
nal prosecution or civil liability or deemed to have engaged in unpro-
fessional conduct as a result of conducting that research without the
informed consent of the research subjects.
(b) A member of an IRB or a monitor is not subject to crimi-
nal prosecution or civil liability or deemed to have engaged in unpro-
fessional conduct as a result of actions done in accordance with this
subtitle.
(c) A legally authorized representative who consents to a deci-
sionally incapacitated individual's participation in research as pro-
vided in this subtitle is not subject to:
(1) criminal prosecution or civil liability for that action; or
(2) liability for any costs associated with the research partici-
pation based solely on the consent.
(d) The immunity provisions of this section shall apply unless
it is shown by a preponderance of the evidence that the person did
not, in good faith, comply with the provisions of this subtitle.
(e) An investigator who knowingly and willfully involves a
decisionally incapacitated individual in research in violation of this
subtitle shall be deemed to have engaged in unprofessional conduct
for purposes of disciplinary action by a licensing authority.
20-514. ADVANCE DIRECTIVES EXECUTED BEFORE EFFECTIVE DATE.
An advance directive authorizing research participation made
prior to October 1, 1998 shall be given effect as provided in this
article.
SECTION 2. AND BE IT FURTHER ENACTED, That this Act
shall take effect on October 1, 1998.
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